Impaired Gamma Interferon Responses against Parvovirus B19 by Recently Infected Children
- 1 November 2000
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 74 (21) , 9903-9910
- https://doi.org/10.1128/jvi.74.21.9903-9910.2000
Abstract
Parvovirus B19 is the causative agent of “fifth disease” of childhood. It has been implicated in a variety of conditions, including unsuccessful pregnancy and rheumatoid arthritis, and is a potential contaminant of blood products. There has been little study of immunity to parvovirus B19, and the exact nature of the protective humoral and cell-mediated immune response is unclear. Immune responses to purified virus capsid proteins, VP1 and VP2, were examined from a cohort of recently infected children and compared with responses from long-term convalescent volunteers. The results demonstrate that antibody reactivity is primarily maintained against conformational epitopes in VP1 and VP2. The unique region of VP1 appears to be a major target for cell-mediated immune responses, particularly in recently infected individuals. We confirm that antibody reactivity against linear epitopes of VP2 is lost shortly after infection but find no evidence of the proposed phenotypic switch in either the subclass of parvovirus B19-specific antibody or the pattern of cytokine production by antigen-specific T cells. The dominant subclass of specific antibody detected from both children and adults was immunoglobulin G1. No evidence was found for interleukin 4 (IL-4) or IL-5 production by isolated lymphocytes from children or adults. In contrast, lymphocytes from convalescent adults produced a typical type 1 response associated with high levels of IL-2 and gamma interferon (IFN-γ). However, we observed a significant (P< 0.001) deficit in the production of IFN-γ in response to VP1 or VP2 from lymphocytes isolated from children. Taken together, these results imply that future parvovirus B19 vaccines designed for children will require the use of conformationally preserved capsid proteins incorporating Th1 driving adjuvants. Furthermore, these data suggest novel mechanisms whereby parvovirus B19 infection may contribute to rheumatoid arthritis and unsuccessful pregnancy.Keywords
This publication has 71 references indexed in Scilit:
- Low IgG3 and high IgG4 subclass levels in children with advanced human immunodeficiency virus-type 1 infection and elevated IgE levelsAnnals of Allergy, Asthma & Immunology, 1999
- CD38+ CD45RBlow CD4+ T cells: a population of T cells with immune regulatory activitiesin vitroEuropean Journal of Immunology, 1998
- Report of a Collaborative Study to Establish the International Standard for parvovirus B19 Serum IgGBiologicals, 1997
- IgG subclass response to human parvovirus B19 infectionClinical and Diagnostic Virology, 1996
- IgG Subclass Antibodies to Human Cytomegalovirus (CMV) in Normal Human Plasma Samples and Immune Globulins and their Neutralizing ActivitiesBiologicals, 1996
- Th1/Th2 cell dichotomy in acquired immunity to Bordetella pertussis: variables in the in vivo priming and in vitro cytokine detection techniques affect the classification of T‐cell subsets as Th1, Th2 or Th0Immunology, 1996
- Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon?Immunology Today, 1993
- Antigenic parvovims B19 coat proteins VP1 and VP2 produced in large quantities in a baculovirus expression systemVirus Research, 1990
- Pure Red-Cell Aplasia of 10 Years' Duration Due to Persistent Parvovirus B19 Infection and Its Cure with Immunoglobulin TherapyNew England Journal of Medicine, 1989
- PARVOVIRUS INFECTIONS AND HYPOPLASTIC CRISIS IN SICKLE-CELL ANAEMIAThe Lancet, 1981